相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Diagnostic uncertainty presented barriers to the timely management of acute thrombotic thrombocytopenic purpura in the United Kingdom between 2014 and 2019
Tom Bull
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)
Rare Disease Registries Are Key to Evidence-Based Personalized Medicine: Highlighting the European Experience
Stefan Koelker et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
ADAMTS13, VWF, and Endotoxin Are Interrelated and Associated with the Severity of Liver Cirrhosis via Hypercoagulability
Hiroaki Takaya et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Outcomes in 1096 patients with severe thrombotic thrombocytopenic purpura before the Caplacizumab era
Andry van de Louw et al.
PLOS ONE (2021)
A modified PLASMIC score including the lactate dehydrogenase/the upper limit of normal ratio more accurately identifies Chinese thrombotic thrombocytopenic purpura patients than the original PLASMIC score
Na Zhao et al.
JOURNAL OF CLINICAL APHERESIS (2020)
Time from suspected thrombotic thrombocytopenic purpura to initiation of plasma exchange and impact on survival: A 10-year provincial retrospective cohort study
Daniel Sawler et al.
THROMBOSIS RESEARCH (2020)
A regimen with caplacizumab, immunosuppression, and plasma exchange prevents unfavorable outcomes in immune-mediated TTP
Paul Coppo et al.
BLOOD (2020)
An assessment of the healthcare services in the Kingdom of Saudi Arabia: An analysis of the old, current, and future systems
Rumaiya Sajjad et al.
INTERNATIONAL JOURNAL OF HEALTHCARE MANAGEMENT (2020)
Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura
M. Scully et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
An open conformation of ADAMTS-13 is a hallmark of acute acquired thrombotic thrombocytopenic purpura
E. Roose et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
A multicenter experience of thrombotic microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG)-TMA01 study
Emre Tekgunduz et al.
TRANSFUSION AND APHERESIS SCIENCE (2018)
Clinical and laboratory diagnosis of TTP: an integrated approach
Thita Chiasakul et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2018)
Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study
Pavan K. Bendapudi et al.
LANCET HAEMATOLOGY (2017)
Thrombotic thrombocytopenic purpura
Johanna A. Kremer Hovinga et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Diagnosis and management of thrombotic thrombocytopenic purpura (TTP) in Australia: findings from the first 5 years of the Australian TTP/thrombotic microangiopathy registry
P. Blombery et al.
INTERNAL MEDICINE JOURNAL (2016)
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura
Flora Peyvandi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy
Eric Mariotte et al.
LANCET HAEMATOLOGY (2016)
Thrombotic thrombocytopenic purpura - analysis of clinical features, laboratory characteristics and therapeutic outcome of 24 patients treated at a Tertiary Care Center in Saudi Arabia
Shahid Iqbal et al.
PAKISTAN JOURNAL OF MEDICAL SCIENCES (2016)
Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: the experience of the Harvard TMA Research Collaborative
Pavan K. Bendapudi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies
Marie Scully et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Clinical features of severe acquired ADAMTS13 deficiency in thrombotic thrombocytopenic purpura: the Korean TTP registry experience
Moon Ju Jang et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2011)
Thrombotic microangiopathy
M. Mortzell et al.
TRANSFUSION AND APHERESIS SCIENCE (2011)
Predictive Features of Severe Acquired ADAMTS13 Deficiency in Idiopathic Thrombotic Microangiopathies: The French TMA Reference Center Experience
Paul Coppo et al.
PLOS ONE (2010)
The utility of patient characteristics in predicting severe ADAMTS13 deficiency and response to plasma exchange
Melissa J. Bentley et al.
TRANSFUSION (2010)
Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura
J. Evan Sadler
BLOOD (2008)
Regional UK TTP Registry: correlation with laboratory ADAMTS 13 analysis and clinical features
Marie Scully et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Acquired thrombotic thrombocytopenic purpura: ADAMTS13 activity, anti-ADAMTS13 autoantibodies and risk of recurrent disease
Bernhard Laemmle et al.
HAEMATOLOGICA (2008)
Laboratory measurement of schistocytes
J. F. Lesesve et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2007)
vAcquired ADAMTS-13 deficiency in pediatric patients with severe sepsis
Trung C. Nguyen et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2007)
Thrombotic thrombocytopenic purpura
JN George
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure
T Ono et al.
BLOOD (2006)
Thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome: a new index predicting response to plasma exchange
BF Wyllie et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
分享论文
